US: FDA health panel endorses booster jab for J&J’s COVID vaccine
Al Jazeera
Health officials are now recommending Americans get booster jabs of the Pfizer, Moderna and J&J coronavirus vaccines.
An advisory panel of the US Food and Drug Administration (FDA) has endorsed booster jabs of Johnson & Johnson’s COVID-19 vaccine amid concerns the J&J single-dose jab is less effective than previously thought.
The FDA’s influential 19-member advisory panel voted unanimously on Friday to recommend a second jab for about 15 million people in the United States who have received a first dose of the J&J vaccine.
A day earlier, the panel recommended a third dose of Moderna’s two-dose vaccine, and it previously endorsed boosters of the Pfizer-BioNTech jab.
More Related News